FDA Investigator Stephen J Mottola

Stephen J Mottola has conducted inspections on 83 sites in 9 countries as of 06 Nov 2022. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
83
Last Inspection Date:
06 Nov 2022
Investigator Role:
FDA Investigator
Redica ID:
100003024
Countries of Inspections:
United States of America, Japan, China, Argentina, Denmark, Egypt, India, Taiwan, Germany
FDA Investigators that have inspected at least one site in common with Stephen J Mottola:
Addam S Reynolds, Adetutu M Gidado, Alberto A Viciedo, Alicia M Mozzachio, Allen Lou, Amy L Singer, Amy M Codella, Amy M Cramer, Anastasia M Shields, Ankur C Patel, Anna Lazar, Annemarie B Randow, Annemarie Bodnar, Anthony J Donato, Atul J Agrawal, Azza Talaat, Barbara J Maulfair, Barbara Jwilimczyk Macri, Bijoy Panicker, Blondell W Johnson, Bogdan Kurtyka, Brandy N Lepage, Brett R Havranek, Cary Greene, Cassandra L Abellard, CDR Rochelle B Young, RPh, MSA, Charles I Ann, Charles J Chacko, Christina N Maurino, Christine M Cerenzio, Craig W Swanson, Daniel J Grabicki, David H Smith, Dawn L Wydner, Deborah B Nixon, Debra J Bennett, Denise M Visco, Investigator, Dennis Cantellops Paite, Devon Jenkins, Diane B Radice, Doan T Nguyen, PharmD, Doreen P Gubbay, Douglas C Kovacs, Edwin Martinez, Emest F Bizjak, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Esteban Beltran, Farhana Khan, Frank J Marciniak, Frederick F Razzaghi, George Pyramides, Gianine E Delade, Gianine E Tompkins, Gobiga Vanniyasingam, Gregson A Joseph, Guerlain Ulysse, Haitao Li, Helen B Ricalde, Helen Verdel, James P Stumpff, James R Birkenstamm, Janet A Rajan, Jason M Sluzynski, Javier E Santos, Javier O Vega, Jawaid Hamid, Jean Blackston Hill, Jeffery B Medwid, PhD, Jeffrey A Sommers, Jenny Sung, Jessica M Monteiro, Jessica S Estriplet, Jogy George, Johnna L Bleem, Jonathan G Matrisciano, Jonathan S Helfgott, Jonee J Mearns, José E Meléndez, Jose M Cayuela, Jose R Hernandez, Joseph F Mcginnis, RPh, Josh Renzo N Ramilo, Joy Rkozlowski Klena, Juanita P Versace, Junho Pak, Justine Tomasso, Karen E D'orazio, Kelli F Dobilas, Kelli Regente, Kelly Doremus, Kelly I Anderson, Kenneth H Williams, Kevin A Gonzalez, Kinh Q Mac, Krishnaiah Yellela, Kristy A Zielny, Kshitij A Patkar, Kyle D Covill, Laishan L Lam, Lata C Mathew, PhD, Lauren L Vajo, Lawrence R Johnson, LCDR Debra Emerson, Li Li, Liatte Kreuger, PharmD, Linda Thai, Lisa Harlan, Loretta Nemchik, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcia D Fields, Maria Estrella, Maria Manzoni, PhD, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Mark R Mcclain, Mary E Storch, Mary Jeanet Mcgarry, Matthew A Spataro, Melba Trivera Clavell, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Meyer J Slobotsky, Michael A Charles, Michael R Klapal, Michael Rosner, Michael Serrano, Miguel Gmanzano Maldonado, Monika Borkowska, Nadeem I Chaudhry, Namita Kothary, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Nerizza B Guerin, Nicholas A Violand, Nicholas L Hunt, Niketa Patel, Nikki S Ramirez, Nina Yang, Pal S Mayasandra, Paraluman S Leonin, Patrick C Klotzbuecher, Paul L Bellamy, Paul Mouris, Peter R Lenahan, Ramanda C Gregory, Raymond L Cheung, Regina T Brown, Remache, Richard A Abate, Robert D Tollefsen, Robert J Martin, Robert W Calais, Robin P Mathew, Rose Ljean Mary, Russell J Glapion, S Lori Brown, PhD MPH, Sachinkumar V Patel, Saleem A Akhtar, Samantha J Bradley, Samir C Gala, Sandra Kershaw, Sarah Adella Fave, Satheesh K Podaralla, Schultz, Sean R Marcsisin, Shahla Parvizi, Sherri J Liu, Shirley S Wen, Sinai I Davis, Sony Mathews, Spiridoula Dimopoulos, Stacey S Degarmo, Stephanie T Durso, Stephenie M Ortiz, Steven M Weinman, Suchan Kim, Susan W Ting, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Tonia F Bernard, Tressa T Lewis, Truong Xuan Nguyen (Andy), Tyanna N Hadley, Unnee Ranjan, Uttaniti Limchumroon (Tom), Valerie C Reed, Victoria Spivak, Vilmary Negron Rodriguez, Wayne J Meyer, William J Leonard, William R Chang, Xiaohan Cai, PhD, Yumi J Hiramine, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu

Stephen J Mottola's Documents

Publish Date Document Type Title
May, 2013 FDA 483 BASF Corporation - Form 483, 2013-05-28
May, 2012 FDA 483 June Jacobs Labs, LLC - Form 483, 2012-05-16
April, 2012 FDA 483 EKR Holdings, Inc. - Form 483, 2012-04-16
November, 2013 EIR Avantor Performance Materials, LLC - EIR, 2013-11-15
March, 2013 FDA 483 QUALIMAX LLC - Form 483, 2013-03-06
March, 2018 EIR MSN Laboratories Private Limited - EIR, 2018-03-09
October, 2012 EIR Integrated Analytical Laboratories, LLC. - EIR, 2012-10-18
July, 2012 FDA 483 Response Validus Pharmaceuticals, Inc. - Form 483R, 2012-07-20
April, 2011 FDA 483 Actavis Elizabeth LLC - Form 483, 2011-04-26
June, 2019 EIR Maprimed S.A. - EIR, 2019-06-07
January, 2020 EIR Sharp Mint Limited - EIR, 2020-01-31
June, 2019 FDA 483 Response Maprimed S.A. - Form 483R, 2019-06-28
May, 2015 EIR Taiho Pharmaceutical Co., Ltd. - EIR, 2015-05-22
December, 2018 EIR Chirogate International Inc. - EIR, 2018-12-06
April, 2011 FDA 483 Response Actavis Elizabeth LLC - Form 483R, 2011-06-15
March, 2014 FDA 483 OHM LABORATORIES INC. - Form 483, 2014-03-18
January, 2011 EIR JAK Diversified II, Inc. dba Multi-Pak Packaging - EIR, 2011-01-31
April, 2011 EIR Actavis Elizabeth LLC - EIR, 2011-04-26
September, 2022 FDA 483 A/S Orthana Kemisk Fabrik - Form 483, 2022-10-21
July, 2012 FDA 483 Validus Pharmaceuticals, Inc. - Form 483, 2012-07-10
January, 2011 FDA 483 JAK Diversified II, Inc. dba Multi-Pak Packaging - Form 483, 2011-01-31
January, 2014 EIR June Jacobs Labs, LLC - EIR, 2014-01-14
September, 2014 FDA 483 Better Health Lab, Inc - Form 483, 2014-09-22
February, 2013 FDA 483 Actavis Elizabeth LLC - Form 483, 2013-02-15
February, 2014 EIR Hikma Pharmaceuticals USA, Inc. - EIR, 2014-02-26
February, 2013 EIR Actavis Elizabeth LLC - EIR, 2013-02-15
May, 2013 EIR BASF Corporation - EIR, 2013-05-28
September, 2022 EIR A/S Orthana Kemisk Fabrik - EIR, 2022-11-04
January, 2013 FDA 483 GE Healthcare Inc. - Form 483, 2013-01-09
February, 2013 FDA 483 Response Actavis Elizabeth LLC - Form 483R, 2013-03-08
November, 2022 FDA 483 Pharmaplast SAE - Form 483, 2022-11-10
January, 2011 FDA 483 Response JAK Diversified II, Inc. dba Multi-Pak Packaging - Form 483R, 2011-02-16
February, 2014 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2014-02-26
January, 2020 FDA 483 Sharp Mint Limited - Form 483, 2020-01-31
March, 2011 FDA 483 June Jacobs Labs, LLC - Form 483, 2011-03-21
April, 2012 FDA 483 Brioschi Pharmaceuticals International LLC - Form 483, 2012-04-25
January, 2014 FDA 483 June Jacobs Labs, LLC - Form 483, 2014-01-14
March, 2018 FDA 483 MSN Laboratories Private Limited - Form 483, 2018-03-09
March, 2013 EIR QUALIMAX LLC - EIR, 2013-03-06
November, 2013 EIR Teva Pharmaceuticals USA, Inc. - EIR, 2013-11-06

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more